share_log

《公司業績》領航醫藥生物(00399.HK)中期純利1.25億元 虧轉盈

"Company performance" pilot Pharmaceutical Biology (00399.HK) medium-term net profit of 125 million yuan turned to profit

即市頭條 ·  Nov 29, 2021 16:42

Pilot Pharmaceutical Biotechnology (00399.HK) reported interim results for the six months ended September, with revenue of 6.63 million yuan, down 7.3% year-on-year. It recorded a net profit of 125 million yuan, a loss of 93.45 million yuan and a profit of 8.54 cents per share compared with the same period last year. No interim interest.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment